However, one industry observer cautions against moving forward with specific GLP-1 claims on packaging until federal agencies ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...

Weight loss drugs have surged in popularity. But Gov. Ned Lamont wants CT’s Medicaid program to discontinue covering them for ...

You may soon be able to eat your Ozempic … sort of. GLP-1 supplements are booming, promising to deliver similar benefits to Ozempic and Wegovy without the pricey injections. The latest contender ...

Popular diabetes and weight-loss drugs known as GLP-1s are helping to boost the biopharma sector's return on investment this ...

As obesity drug developers compete for the highest weight-loss efficacy, experts contend that overall health ...

Experts aren’t really on board with taking these new, buzzy, multi-ingredient supplements that claim to help with insulin ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...